Base Immune
Biotechnology · Vaccines
Venture roundlatest round · Oct 2025 · 13 mo ago
3backers · Hoxton Ventures, IQ Capital
$86kgrants · 1 grant · CORDIS
21team · UK accounts · Dec 2025 · +24% in a year
Key facts
These are the key facts about Base Immune on Alion as of Nov 13, 2026. Base Immune is headquartered in London, United Kingdom. It was founded in 2019.
- Headquarters
- London, United KingdomAlion company profile, updated Sep 28, 2026
- Founded
- 2019Alion company profile, updated Sep 28, 2026
- Employees
- 10+Alion company profile, an estimated range
- Visa sponsorship, United Kingdom
- A-ratedUK Home Office · checked Nov 12, 2026
Official records
Funding and backers
Latest round
Venture round
Oct 2025 · 13 mo ago
Team
21
UK accounts · Dec 2025 · +24% in a year
Grants
$86k
1 grant · CORDIS
Backers
3
Hoxton Ventures, IQ Capital
The money's age
Due for its next round
13 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 1, 2025
Raised a round Venture round
Dec 6, 2024
Raised a round Venture round
Jan 8, 2024
Raised a round Venture round
Dec 1, 2023
Won a grant $86k · CORDIS
Aug 15, 2023
Raised a round Venture round
Nov 29, 2022
Raised a round Venture round
Sep 15, 2021
Raised a round Venture round
Mar 18, 2021
Raised a round Venture round
Oct 30, 2019
Founded per the company register
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Dec 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Jan 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Dec 2023 | $86k | — | CORDIS |
| Venture round | Aug 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Nov 2022 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Sep 2021 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Mar 2021 | — | — | find-and-update.company-information.service.gov.uk |
Registers and programsofficial lists and records that name the company
| Legal entity | BASEIMMUNE LTD | Companies House |
| Registered | 30 Oct 2019 |
Backed byfrom the funds' portfolios and accelerator catalogs
Hoxton Ventures 
IQ Capital 
The Creator Fund Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Innovators in natural vaccine technology. Explore rapidly engineered, scalable vaccine technologies at Hexamer Therapeutics.
Protecting Our Future. ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100…
Animal Vaccine Delivery in Just 30 Minutes. Experience the world's fastest vaccine delivery. Get a complete range of vaccines delivered…
GIVAX is developing a new class of vaccines to protect children from severe gastroenteritis caused by rotavirus and norovirus. Leveraging…
EpiVax leads the industry in immunogenicity assessment and sequence optimization for biologic therapeutics and vaccines. Utilizing…
Positioned to deliver revolutionary off-the-shelf cancer vaccines. OUR CORE MISSION.
Visa sponsorship
A-rated
Sponsor licence
Skilled Worker
Visa route
0
Open roles in United Kingdom
In the register as Baseimmune Ltd, London
Other sponsors in the same field
Microneedle Solutions
GSK plc
Alert me
UK Home Office · checked Nov 12, 2026 · Visa details by country
Financials
Total raised
$86k
Latest round
Venture - Series Unknown
Funding rounds
8
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | — | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Grant | 2023 | $86k | Details |
| Venture - Series Unknown | 2023 | — | Details |
| Venture - Series Unknown | 2022 | — | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Venture - Series Unknown | 2021 | — | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Baseimmune Announces Strategic Expansion into Fibrosis with Lead Program Targeting Idiopathic Pulmonary Fibrosis (IPF)
Baseimmune unveils a new multi-pathway immunotherapy strategy, applying its computational protein design platform to develop next-generation therapies for fibrosis. Fibrosis is driven by
Read more
Report
Baseimmune: £9 Million In Funding Raised To Predict Future Pathogen Mutations To Generate Novel Vaccines
Baseimmune - a biotech company that uses proprietary, deep learning AI to predict future pathogen mutations to generate novel vaccines - recently announced the closing of £9 million in Series A funding led by new investors MSD Global Health Innovation Fun
Read more
Report
Baseimmune launches for AI-based vaccine development
Chemical & Engineering News (C&EN): Keeping you up to date with the chemistry news that matters most. Published by the American Chemical Society.
Read more
Report
Baseimmune获得1130万美元A轮融资_腾讯新闻
Baseimmune是一家疫苗研发商专注于开发针对高度可变病原体的可塑性基础免疫疫苗借助数据驱动平台用于分析病原体基因组学、蛋白质组学、流行病学、进化和临床数据以此来有效对抗当前和未来未知菌株和变体的疫苗抗原近日Baseimmune宣布完成1130万美元的A轮融资本轮融资由新投资者MSD Global Health Innovation F...
Read more
Report
Baseimmune: $11.3 Million Closed To Use AI For Predicting Future Pathogen Mutations To Generate Novel Vaccines
Baseimmune - a biotech company that uses proprietary and deep learning AI to predict future pathogen mutations to generate novel vaccines - announced the close of $11.3 million £9 million in Series A funding led by new investors MSD Global Health Innovati
Read more
Report
Series A financing at Baseimmune to advance vaccine candidates
Baseimmune Ltd. has closed $11.3 million (£9 million) in series A funding. The company uses proprietary, deep learning artificial intelligence (AI) to predict future pathogen mutations to generate novel vaccines.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London
United Kingdom
HQ
404 Err….or
10-50 est. staff
Apex, 1 Tribeca Walk, London, NW1 0QE
How to cite this page
Alion, "Base Immune: key facts", as of Nov 13, 2026. https://alion.io/company/baseimmune
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0